The Drug Enforcement Agency recently released its much-anticipated Interim Final Rule (IFR) on electronic prescribing of controlled substances. While additional clarification is needed from DEA, the rule opens the door for electronic transmission of controlled-substance prescriptions to pharmacies and removes a significant barrier to the overall use of electronic prescribing.
